Vegfxta Solution for Infusion

Welcome to the information page for Vegfxta Solution for Infusion, brought to you by Fresenius Kabi India Pvt Ltd. This product contains the active ingredient Bevacizumab (100mg) and is indicated for Cancer of colon and rectum,Ovarian cancer,Cervical cancer,Kidney cancer,Brain tumor,Non-small cell lung cancer. Here, you can find crucial details, including its uses, pricing, and options to add it to your wishlist or compare it with similar medications.

MRP: ₹ 13026.09
Packing: 4.0 ml in 1 vial
Salt Combination: Bevacizumab (100mg)
Brand: Fresenius Kabi India Pvt Ltd
Uses: Cancer of colon and rectum,Ovarian cancer,Cervical cancer,Kidney cancer,Brain tumor,Non-small cell lung cancer

Description

Vegfxta Solution for Infusion is an anticancer medication
It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer
It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing
Vegfxta Solution for Infusion is an effective medicine, first-line option when used together with other cancer medicines
It is given as an infusion
That means you get it through a small needle in your vein or through a port, which is a device placed under your skin
The doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing
You keep taking Vegfxta Solution for Infusion as long as your disease is controlled and your side effects are manageable
Your doctor will determine whether you should stop taking it or not
You may be advised to check blood pressure and levels of protein in urine while you are taking this medication.
The most common side effects of this medicine include nosebleeds, headache, high blood pressure, rhinitis, protein in urine, change in taste, dry skin, bleeding, lacrimation disorder, back pain, and exfoliative dermatitis
Inform your doctor that you are taking this medication before undergoing any surgical procedure, as the drug has ability to lower the ability of wound healing
Other than this, it also enhances your risk of bleeding thus if you notice any unusual bleeding or bleeding consult with your doctor immediately.
Inform your doctor if you are pregnant, planning pregnancy or breastfeeding
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.

Cautions

Liver:	SAFE IF PRESCRIBED: Vegfxta Solution for Infusion is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Vegfxta Solution for Infusion may not be needed in these patients. Please consult your doctor.
Kidney:	SAFE IF PRESCRIBED: Vegfxta Solution for Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Vegfxta Solution for Infusion may not be needed in these patients. Please consult your doctor.
Driving:	UNSAFE: Vegfxta Solution for Infusion may cause side effects which could affect your ability to drive.^Sleepiness and fainting have been reported with Vegfxta Solution for Infusion and this may impair your ability to drive.
Breast feeding:	CONSULT YOUR DOCTOR: Vegfxta Solution for Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnency:	CONSULT YOUR DOCTOR: Vegfxta Solution for Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Vegfxta Solution for Infusion. Please consult your doctor.
Drug Action:	Vascular endothelial growth factor (VEGF) inhibitor
Therapeutic class:	ANTI NEOPLASTICS
Habit Forming:	No
Chemical Class:	Monoclonal antibody (mAb)